We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

96 hedge funds and large institutions have $47.5M invested in Chimerix, Inc. in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more call options, than puts

Call options by funds: $41K | Put options by funds: $13K

0% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 27

1% less funds holding

Funds holding: 9796 (-1)

10% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 30

28% less capital invested

Capital invested by funds: $66.3M → $47.5M (-$18.9M)

Holders
96
Holders Change
-1
Holders Change %
-1.03%
% of All Funds
1.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
27
Reduced
30
Closed
27
Calls
$41K
Puts
$13K
Net Calls
+$28K
Net Calls Change
-$24K
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$403K -$189K -149,419 -31%
JP Morgan Chase
27
JP Morgan Chase
New York
$391K -$32.6K -25,725 -7%
XT
28
XTX Topco
Cayman Islands
$383K +$105K +82,951 +36%
UBS Group
29
UBS Group
Switzerland
$345K +$114K +90,166 +46%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$338K +$259K +204,733 +274%
Connor, Clark & Lunn Investment Management (CC&L)
31
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$334K +$70.2K +55,387 +25%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$247K -$289K -227,896 -53%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$196K +$206K +162,156 New
Assenagon Asset Management
34
Assenagon Asset Management
Luxembourg
$193K -$145K -114,117 -42%
EAM
35
Erste Asset Management
Austria
$150K
Verition Fund Management
36
Verition Fund Management
Connecticut
$147K +$154K +121,900 New
MAM
37
Marquette Asset Management
Minnesota
$114K +$120K +94,582 New
YIH
38
Y-Intercept (HK)
Hong Kong
$114K +$119K +93,836 New
SC
39
Shay Capital
New York
$101K +$106K +83,385 New
HF
40
HRT Financial
New York
$100K +$106K +83,401 New
Corient Private Wealth
41
Corient Private Wealth
Florida
$99.3K +$22.8K +18,000 +28%
Ameriprise
42
Ameriprise
Minnesota
$86.1K +$3.71K +2,927 +4%
CANY
43
Caxton Associates (New York)
New York
$83.8K -$129K -101,606 -59%
Group One Trading
44
Group One Trading
Illinois
$83K +$86.9K +68,587 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$75K +$72.8K +57,442 +1,193%
RJA
46
Raymond James & Associates
Florida
$71.6K -$6.34K -5,000 -8%
E
47
Ergoteles
New York
$67.4K +$70.5K +55,666 New
CSS
48
Cubist Systematic Strategies
Connecticut
$66.8K +$13.6K +10,757 +24%
Squarepoint
49
Squarepoint
New York
$66.4K +$69.6K +54,910 New
LCM
50
Laurion Capital Management
New York
$61.5K +$64.4K +50,800 New

CMRX Hedge Fund Activity: Q2 2023 in Review

96 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q2 2023, worth a combined $47.5M — down 28% from $66.3M a quarter earlier.

Fund positioning in CMRX was balanced in Q2 2023: 27 funds opened new positions, 27 closed out, 27 added to existing stakes and 30 trimmed.

The largest buyer was Monaco Asset Management, adding an estimated $2.52M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $9.24M sold.

  • 96 institutional investors held Chimerix, Inc. (CMRX) as of Q2 2023, down from 97 in Q1 2023.
  • Funds reported $47.5M of Chimerix, Inc. stock for Q2 2023, down 28% quarter-over-quarter.
  • 27 funds opened new Chimerix, Inc. positions in Q2 2023 and 27 closed out, a net change of 0 holders.
  • The largest Chimerix, Inc. buyer in Q2 2023 was Monaco Asset Management, an estimated $2.52M added.
  • The largest Chimerix, Inc. seller in Q2 2023 was Rubric Capital Management (New York), an estimated $9.24M sold.

Based on aggregated 13F filings for Q2 2023.